Extended trial tests pill for rare hormone disorder
NCT ID NCT04261712
Summary
This study follows patients who previously participated in earlier trials of paltusotine, an oral medication for acromegaly. Researchers want to understand the long-term safety and effectiveness of continued treatment. The study tracks side effects and measures hormone levels over time in 43 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Crinetics Study Site
Los Angeles, California, 90095, United States
-
Crinetics Study Site
Chicago, Illinois, 60611, United States
-
Crinetics Study Site
Boston, Massachusetts, 02114, United States
-
Crinetics Study Site
Columbus, Ohio, 43210, United States
-
Crinetics Study Site
Pittsburgh, Pennsylvania, 15212, United States
-
Crinetics Study Site
Pittsburgh, Pennsylvania, 15213, United States
-
Crinetics Study Site
Dallas, Texas, 75231, United States
-
Crinetics Study Site
Curitiba, Paraná, 80030-110, Brazil
-
Crinetics Study Site
Rio de Janeiro, 20231, Brazil
-
Crinetics Study Site
Rio de Janeiro, 21941, Brazil
-
Crinetics Study Site
São Paulo, 01228, Brazil
-
Crinetics Study Site
München, 80336, Germany
-
Crinetics Study Site
Athens, 10676, Greece
-
Crinetics Study Site
Thessaloniki, 54642, Greece
-
Crinetics Study Site
Budapest, 1062, Hungary
-
Crinetics Study Site
Budapest, 1083, Hungary
-
Crinetics Study Site
Pécs, 7624, Hungary
-
Crinetics Study Site
Belgrade, 11000, Serbia
-
Crinetics Study Site
Coventry, United Kingdom
-
Crinetics Study Site
Leeds, LS97TF, United Kingdom
-
Crinetics Study Site 1
Athens, 11527, Greece
-
Crinetics Study Site 2
Athens, 11527, Greece
Conditions
Explore the condition pages connected to this study.